Utilizing 26 genetic instruments for IL6R blockade, this study offers evidence suggesting that downregulation of IL6 signaling pathways may confer protective effect against the development of COPD and asthma. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.